Stonehouse Jon P has filed 37 insider transactions across 2 companies since December 2022.
Most recent transaction: a grant/award of 421 shares of BIOCRYST PHARMACEUTICALS INC ($BCRX) on February 27, 2026.
Activity breakdown: 1 open-market purchase and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | Director | A | Common Stock | 421 | $8.75 | 1,403,850.0000 | 219,885,000 | 0.03% | 0.00% |
| March 2, 2026 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | Director | M | Emp. Stock Option (Right to Buy) | 305995 | $0.00 | 0.0000 | 219,885,000 | 100.00% | 0.14% |
| March 2, 2026 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | Director | D | Common Stock | 305995 | $8.64 | 1,403,850.0000 | 219,885,000 | 17.90% | 0.14% |
| March 2, 2026 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | Director | M | Common Stock | 305995 | $3.22 | 1,709,845.0000 | 219,885,000 | 21.80% | 0.14% |
| Dec. 19, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | Chief Executive Officer | F | Common Stock | 61793 | $7.41 | 1,403,429.0000 | 219,885,000 | 4.22% | 0.03% |
| Dec. 18, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | Chief Executive Officer | G | Common Stock | 20000 | $0.00 | 1,465,222.0000 | 219,885,000 | 1.35% | 0.01% |
| Dec. 18, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | Chief Executive Officer | G | Common Stock | 10000 | $0.00 | 1,465,222.0000 | 219,885,000 | 0.69% | 0.00% |
| Dec. 18, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | Chief Executive Officer | G | Common Stock | 10000 | $0.00 | 1,465,222.0000 | 219,885,000 | 0.69% | 0.00% |
| Dec. 12, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | Chief Executive Officer | F | Common Stock | 27368 | $7.57 | 1,465,222.0000 | 219,885,000 | 1.83% | 0.01% |
| Nov. 13, 2025 | Metsera, Inc. | $MTSR | Stonehouse Jon P | Not found | D | Common Stock | 2688 | $0.00 | 0.0000 | 105,376,189 | 100.00% | 0.00% |
| Nov. 13, 2025 | Metsera, Inc. | $MTSR | Stonehouse Jon P | Not found | D | Stock Option (right to buy) | 47730 | $0.00 | 0.0000 | 105,376,189 | 100.00% | 0.05% |
| Nov. 13, 2025 | Metsera, Inc. | $MTSR | Stonehouse Jon P | Not found | A | Restricted Stock Unit | 2688 | $0.00 | 2,688.0000 | 105,376,189 | 9999.99% | 0.00% |
| April 28, 2025 | Metsera, Inc. | $MTSR | Stonehouse Jon P | Not found | A | Stock Option (Right to Buy) | 47730 | $19.81 | 47,730.0000 | 105,050,219 | 9999.99% | 0.05% |
| Dec. 19, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | A | Common Stock | 362100 | $0.00 | 1,523,119.0000 | 206,905,000 | 31.19% | 0.18% |
| Dec. 19, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | F | Common Stock | 14010 | $7.39 | 1,509,109.0000 | 206,905,000 | 0.92% | 0.01% |
| Dec. 20, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | G | Common Stock | 20000 | $0.00 | 1,489,109.0000 | 206,905,000 | 1.33% | 0.01% |
| Dec. 20, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | G | Common Stock | 10000 | $0.00 | 1,489,109.0000 | 206,905,000 | 0.68% | 0.00% |
| Dec. 20, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | G | Common Stock | 10000 | $0.00 | 1,489,109.0000 | 206,905,000 | 0.68% | 0.00% |
| Dec. 19, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | A | Emp. Stock Option (Right to Buy) | 750250 | $0.00 | 750,250.0000 | 206,905,000 | 9999.99% | 0.36% |
| Dec. 14, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | F | Common Stock | 27525 | $7.53 | 1,141,019.0000 | 206,905,000 | 2.36% | 0.01% |
| May 13, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | P | Common Stock | 30000 | $5.55 | 1,167,770.0000 | 192,198,000 | 2.64% | 0.02% |
| Jan. 3, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | G | Common Stock | 20000 | $0.00 | 1,134,770.0000 | 192,198,000 | 1.73% | 0.01% |
| Jan. 3, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | G | Common Stock | 10000 | $0.00 | 1,134,770.0000 | 192,198,000 | 0.89% | 0.01% |
| Jan. 3, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | G | Common Stock | 10000 | $0.00 | 1,134,770.0000 | 192,198,000 | 0.89% | 0.01% |
| Dec. 19, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | F | Common Stock | 14089 | $6.05 | 1,134,770.0000 | 185,908,000 | 1.23% | 0.01% |
| Dec. 14, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | A | Emp. Stock Option (Right to Buy) | 595000 | $0.00 | 595,000.0000 | 185,908,000 | 9999.99% | 0.32% |
| Dec. 14, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | F | Common Stock | 13592 | $6.43 | 1,148,859.0000 | 185,908,000 | 1.17% | 0.01% |
| Dec. 14, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | A | Common Stock | 127500 | $0.00 | 1,162,451.0000 | 185,908,000 | 12.32% | 0.07% |
| June 13, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | G | Common Stock | 25000 | $0.00 | 1,034,794.0000 | 185,908,000 | 2.36% | 0.01% |
| March 21, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | M | Emp. Stock Option (Right to Buy) | 31055 | $0.00 | 305,995.0000 | 185,908,000 | 9.21% | 0.02% |
| March 21, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | M | Common Stock | 31055 | $3.22 | 1,059,794.0000 | 185,908,000 | 3.02% | 0.02% |
| Feb. 1, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | M | Common Stock | 100000 | $5.45 | 1,128,739.0000 | 185,908,000 | 9.72% | 0.05% |
| Dec. 29, 2022 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | G | Common Stock | 5000 | $0.00 | 1,028,739.0000 | 0 | 0.49% | 0.00% |
| Dec. 29, 2022 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | G | Common Stock | 5000 | $0.00 | 1,028,739.0000 | 0 | 0.49% | 0.00% |
| Dec. 29, 2022 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | G | Common Stock | 10000 | $0.00 | 1,028,739.0000 | 0 | 0.96% | 0.00% |
| Feb. 1, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | S | Common Stock | 100000 | $10.38 | 1,028,739.0000 | 185,908,000 | 8.86% | 0.05% |
| Feb. 1, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | Stonehouse Jon P | President & CEO | M | Emp. Stock Option (Right to Buy) | 100000 | $0.00 | 0.0000 | 185,908,000 | 100.00% | 0.05% |